VieCure
VieCure has developed an AI-powered informatics software platform for oncology, assisting clinicians in creating personalized treatment plans and managing patient care from diagnosis through follow-up.
Services
VieCure offers a proprietary artificial intelligence informatics software platform designed for oncology. The platform features a clinical inference engine and point-of-care decision support system. It assists clinicians in generating personalized treatment plans and managing patient treatment from diagnosis through therapy and follow-up care. Key services include integrated tele-oncology, e-prescribing, and medication management, supported by partnerships, such as with DrFirst.
Products
VieCure's comprehensive suite includes several products: a patient mobile app, a physician mobile app, and a practice operating system. It features an AI inference engine, a codified content library, and data and analytics solutions. These products support personalized healthcare treatment plans for oncology patients and integrate with third-party solutions like those from DrFirst.
Collaborations
VieCure collaborates with clinical partners and commercial organizations to enhance its services. Clinical partners include Dothan Hematology Oncology, Oncology Care Partners, and the American Oncology Network. Commercial collaborations feature companies like Adaptive Biotechnologies, Cencora, DrFirst, and Microsoft Azure. These partnerships expand the platform's capabilities and improve patient outcomes.
Certifications
VieCure holds several important certifications that underline its commitment to quality and compliance. The company is certified by the Drummond Group, Surescripts, and ONC Health IT. These certifications ensure that VieCure's platform meets stringent regulatory standards and is trusted by healthcare providers.
Headquarters
VieCure is headquartered at 5680 Greenwood Plaza Blvd, Suite 350, Greenwood Village, CO, 80111. The headquarters serves as the central hub for its operations, research, and development activities, supporting its mission to enhance oncology treatment through advanced AI platforms.